EDITORIAL CONTRIBUTORS

Debora Araujo, Associate Director, Clinical Site Budget & Payments
Boehringer Ingelheim
Andrew Benzie, Head, Patients in Partnership
GlaxoSmithKline
Katherine Capperella, Global Patient Engagement Leader
Janssen
Amanda Ceres, Sr. Consultant
Halloran Consulting Group
Janice Chang, SVP, Global Operations
TransCelerate Biopharma
John Carlos Diaz
Independent Consultant
Rob DiCicco, VP, Clinical Innovation & Digital Platforms
GlaxoSmithKline
Dominic Galante, CMO, Quality & Population Health Solutions
Precision for Value
David Gilliland
Independent Consultant
Laurie Halloran, President & CEO
Halloran Consulting Group
Beth Harper, President
Clinical Performance Partners
Beverly Harrison, HEad of Patient Support
Janssen
Mathini Ilancheran, Principal Analyst, R&D
Beroe
Steven Immergut, VP, Head of Communications & Advocacy Relations
Bayer
Jacqueline Johnson North, CEO & Cofounder
IAOCR
Patricia Leuchten, CEO
The Avoca Group
Barbara Lopez Kunz, Global Chief Executive
DIA
Christopher McSpiritt, Director, R&D Consulting
Paragon Solutions
Roger Mills
Independent Consultant
Jason Monteleone, President
Pivotal Financial Consulting
Matthew Roe, Faculty Director
Duke Clinical Research Institute
Michelle Rose, Principal Consultant
Halloran Consulting Group
David Rosen, Co-chair, Life Science Practice
Foley & Lardner
Kunal Sampat, Sr. Manager, Clinical Research
Abbott Vascular
Roslyn Schneider, Global Patient Affairs Lead
Pfizer
Kathryn Ticknor, Sr. Research Manager
Inspire
John Whyte, Director
U.S. FDA
Kenneth Wu
Independent Consultant